E25: Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV
How I Invest with David Weisburd
00:00
Introduction
Results of a phase one study on a drug for HIV treatment show safety and effectiveness, with no serious adverse events observed in patients. Antiretroviral withdrawal study also indicates an effective immune response in all patients.
Transcript
Play full episode
